Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:January 15, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:January 15, 2016Withdrawn
Condition(s):Coronary Artery DiseaseLast Updated:October 5, 2017Completed
Condition(s):Cardiovascular DiseasesLast Updated:August 30, 2022Completed
Condition(s):Familial HypercholesterolemiaLast Updated:December 14, 2023Enrolling by invitation
Condition(s):Heart FailureLast Updated:July 5, 2023Recruiting
Condition(s):Childhood and Adolescence Cancer (Survivors and Deceased)Last Updated:March 6, 2024Active, not recruiting
Condition(s):AtherosclerosisLast Updated:October 7, 2011Completed
Condition(s):Physical Activity; Coronary Artery DiseaseLast Updated:November 30, 2023Completed
Condition(s):Obesity; Metabolic SyndromeLast Updated:July 1, 2011Completed
Condition(s):Myocardial InfarctionLast Updated:December 11, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.